Skip to search.
 TSX Down 0.08% TSX Ventures Up 0.73%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
5.10 Down 0.25(4.67%) Feb 5, 3:59PM EST
|After Hours : 5.05 Down 0.05 (0.98%) Feb 5, 7:51PM EST
Prev Close:5.35
Open:5.33
Bid:5.05 x 300
Ask:5.50 x 200
1y Target Est:13.50
Beta:2.4557
Earnings Date:Feb 24 - Feb 29 (Est.)
Day's Range:4.94 - 5.40
52wk Range:4.66 - 14.93
Volume:2,512,706
Avg Vol (3m):3,174,160
Market Cap:667.53M
P/E (ttm):N/A
EPS (ttm):-1.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
ZIOPDown 4.67%667.53M
IMGNDown 4.26%665.15M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):252.17
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.40
Quarterly EPS Est (Dec-15) :-0.07
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, employs gene expression, control, and cell technologies to deliver cell-based therapies for the treatment of cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback